Internal Medicine, Clinical Cardiatric Electrophysiology · Lafayette, LA
NPI
1548451677
Since 2007
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
7
Medicare group memberships
Hospitals
5
Hospital affiliations
443 Heymann Blvd, Suite B
Lafayette, LA, 70503
Phone (337) 289-8429
Groups this clinician bills Medicare through
Medicare paid, 2024
$720K
17,114 services
Medicare patients, 2024
2,168
Average age 76
Drug cost, 2024
$1.6M
9,696 prescriptions
Company payments, 2025
$1,775
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marc N Saad was code 93296 (external electrocardiographic monitoring), 3,183 times for 1,044 patients. In total Marc N Saad billed 17,114 services in 118 codes, and Medicare paid $720K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-09-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93296 External Electrocardiographic Monitoring | Office | 3,183 | 1,044 | $12.82 | $41K |
| 93294 External Electrocardiographic Monitoring | Office | 2,366 | 779 | $18.97 | $45K |
| 93000 Electrocardiogram | Office | 1,705 | 937 | $9.73 | $17K |
| 93298 External Electrocardiographic Monitoring | Office | 1,447 | 210 | $64.37 | $93K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,094 | 658 | $11.98 | $13K |
| 99214 Office E&M - Established | Office | 1,005 | 645 | $83.71 | $84K |
| 93295 External Electrocardiographic Monitoring | Office | 847 | 296 | $23.26 | $20K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 809 | 92 | $42.93 | $35K |
| 93280 External Electrocardiographic Monitoring | Office | 681 | 526 | $50.71 | $35K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 575 | 59 | $42.27 | $24K |
| 93228 Electrocardiogram | Office | 295 | 280 | $16.89 | $4,983 |
| 99204 Office E&M - New | Office | 198 | 198 | $112.52 | $22K |
| 80048 Clinical Chemistry | Office | 190 | 164 | $8.26 | $1,570 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 166 | 61 | $34.18 | $5,674 |
| 85027 Blood Count | Office | 153 | 136 | $6.31 | $966 |
By year: 2022 $766K for 18,484 services; 2023 $749K for 18,172 services; 2024 $720K for 17,114 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80048 Clinical Chemistry | 190 | 164 | $8.26 | $1,570 |
| 85027 Blood Count | 153 | 136 | $6.31 | $966 |
| 83735 Clinical Chemistry | 148 | 130 | $6.57 | $972 |
| 80053 Clinical Chemistry | 13 | 13 | $10.35 | $135 |
Medicare prescription drug claims, 2024
In 2024, the drug Marc N Saad prescribed most often to Medicare patients was Sotalol (Sotalol Hcl), with 1,342 prescriptions and refills. In total Marc N Saad wrote 9,696 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sotalol Sotalol Hcl | 1,342 | 2,646 | 307 | $20K |
| Metoprolol Succinate Generic | 1,133 | 2,367 | 291 | $12K |
| Eliquis Apixaban | 1,029 | 1,538 | 188 | $869K |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 462 | 856 | 114 | $7,495 |
| Flecainide Acetate Generic | 383 | 705 | 86 | $13K |
| Atorvastatin Calcium Generic | 331 | 773 | 88 | $3,592 |
| Amlodipine Besylate Generic | 269 | 624 | 78 | $1,533 |
| Xarelto Rivaroxaban | 264 | 389 | 47 | $214K |
| Entresto Sacubitril/Valsartan | 246 | 333 | 51 | $204K |
| Furosemide Generic | 236 | 484 | 71 | $732 |
| Carvedilol Generic | 234 | 494 | 65 | $1,772 |
| Ranolazine Er Ranolazine | 231 | 426 | 62 | $20K |
| Doxycycline Hyclate Generic | 229 | 229 | 223 | $954 |
| Amiodarone Hcl Generic | 210 | 425 | 74 | $3,045 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 207 | 207 | 202 | $1,212 |
Brand drugs: 1,835 claims; generic drugs: 7,861 claims; opioid claims: 208.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marc N Saad $1,775 ($1,775 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbott Laboratories with $1,333.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 17 | $1,333 |
| Kestra Medical Technology Services, Inc. | 2 | $89.03 |
| Biotronik Inc. | 1 | $53.33 |
| Cardiva Medical, Inc. | 2 | $50.81 |
| AtriCure, Inc. ATRC | 2 | $42.87 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $35.43 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $24.47 |
| Pfizer Inc. PFE | 1 | $24.13 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $23.32 |
| Ethicon US, LLC JNJ | 1 | $19.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.